Blood cancer find raises new treatment hopes


16-06-2020
As part of the study the researchers also tested how existing anti-leukaemia drug azacitidine affected the Cdx2 gene.
 
New QIMR Berghofer research has identified how an early genetic change in blood and bone marrow cells paves the way for the development of some blood cancers. The discovery provides a new target for treatment of the blood cancers myelodysplastic syndrome (MDS) and acute myeloid leukaemia (AML). MDS is often a ...